Bone Height Gain Following Transcrestal Sinus Floor Elevation Using Piezoelectric Surgery Versus … (NCT03944811) | Clinical Trial Compass
CompletedNot Applicable
Bone Height Gain Following Transcrestal Sinus Floor Elevation Using Piezoelectric Surgery Versus The Conventional Osteotome Technique
Egypt24 participantsStarted 2019-09-01
Plain-language summary
Missing teeth usually result in functional and cosmetic deficits. Traditionally, they have been restored with dentures or fixed bridges. However, dental implants represent an excellent alternative which rely on the maintenance of a direct structural and functional connection between living bone and implant surface, which is termed osseointergration. When sufficient bone is available in maxilla, implant rehabilitation has shown high success rates of 84-92 %. Atrophy of the alveolar crest and pneumatization of the maxillary sinus limits the quality and quantity of residual bone, therefore complicating the placement of implants in the posterior maxillary area.
Who can participate
Age range20 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Patients having one missing upper posterior tooth residual bone height beneath maxillary sinus from 5-8 mm.
* A minimum of 6 mm residual bone width at site of implant placement.
* The recipient site of the implant should be free from any pathological conditions.
* No diagnosed bone disease or medication known to affect bone metabolism.
* Patients who are cooperative, motivated and hygiene conscious.
* Patients having adequate inter-occlusal space of 8-10 mm.
Exclusion Criteria:
* Systemic conditions/diseases that contraindicate surgery.
* Radiation therapy in the head and neck region or chemotherapy during the 12 months prior to surgery.
* Patients who have any habits that might jeopardize the osseointegration process, such as current smokers.
* Patients with parafunctional habits that produce overload on implant, such as bruxism and clenching.
* Patients that have any pathology in the maxillary sinuses.